Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivar Roots

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
British Journal of Clinical Pharmacology|December 21, 2002
MDR1 genotypes do not influence the absorption of a single oral dose of 1 mg digoxin in healthy white malesThomas Gerloff, Melanie Schaefer, Andreas Johne, et al.
Cardiology|June 27, 2008
Endothelin-1 gene variant Lys198Asn and plasma endothelin level in obstructive sleep apneaKonstanze Diefenbach, Kathrin Kretschmer, Steffen Bauer, et al.
Pharmacogenomics|July 4, 2008
Genetic variants in FKBP5 affecting response to antidepressant drug treatmentJulia Kirchheiner, Rainer Lorch, Elena Lebedeva, et al.
Clinical Pharmacology and Therapeutics|August 2, 2003
Influence of CYP2C9 polymorphisms on the pharmacokinetics and cholesterol-lowering activity of (-)-3S,5R-fluvastatin and (+)-3R,5S-fluvastatin in healthy volunteersJulia Kirchheiner, Dirk Kudlicz, Christian Meisel, et al.
Journal of Clinical Pharmacology|October 1, 2003
MDR1 haplotypes do not affect the steady-state pharmacokinetics of cyclosporine in renal transplant patientsIngrid Mai, Elke Störmer, Mark Goldammer, et al.
Clinical Pharmacology and Therapeutics|October 19, 2002
The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatmentJürgen Brockmöller, Julia Kirchheiner, Jürgen Schmider, et al.
European Journal of Clinical Pharmacology|September 19, 2003
Beta 2-adrenergic receptor polymorphism and susceptibility to primary congenital and primary open angle glaucomaKivanc Güngör, Mehtap Ozkur, Ingolf Cascorbi, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 12, 2003
Implications of pharmacogenetics for individualizing drug treatment and for study designChristian Meisel, Thomas Gerloff, Julia Kirchheiner, et al.
Genetic Testing|October 6, 2006
Systematic analysis of sequence variability of the endothelin-1 gene: a prerequisite for association studiesKonstanze Diefenbach, Farhad Arjomand-Nahad, Christian Meisel, et al.
European Journal of Clinical Pharmacology|September 17, 2004
Impact of cytochrome P-450 inhibition by cimetidine and induction by carbamazepine on the kinetics of hypericin and pseudohypericin in healthy volunteersAndreas Johne, Elke S Perloff, Steffen Bauer, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
British Journal of Clinical Pharmacology|December 21, 2002
MDR1 genotypes do not influence the absorption of a single oral dose of 1 mg digoxin in healthy white malesThomas Gerloff, Melanie Schaefer, Andreas Johne, et al.
Cardiology|June 27, 2008
Endothelin-1 gene variant Lys198Asn and plasma endothelin level in obstructive sleep apneaKonstanze Diefenbach, Kathrin Kretschmer, Steffen Bauer, et al.
Pharmacogenomics|July 4, 2008
Genetic variants in FKBP5 affecting response to antidepressant drug treatmentJulia Kirchheiner, Rainer Lorch, Elena Lebedeva, et al.
Clinical Pharmacology and Therapeutics|August 2, 2003
Influence of CYP2C9 polymorphisms on the pharmacokinetics and cholesterol-lowering activity of (-)-3S,5R-fluvastatin and (+)-3R,5S-fluvastatin in healthy volunteersJulia Kirchheiner, Dirk Kudlicz, Christian Meisel, et al.
Journal of Clinical Pharmacology|October 1, 2003
MDR1 haplotypes do not affect the steady-state pharmacokinetics of cyclosporine in renal transplant patientsIngrid Mai, Elke Störmer, Mark Goldammer, et al.
Clinical Pharmacology and Therapeutics|October 19, 2002
The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatmentJürgen Brockmöller, Julia Kirchheiner, Jürgen Schmider, et al.
European Journal of Clinical Pharmacology|September 19, 2003
Beta 2-adrenergic receptor polymorphism and susceptibility to primary congenital and primary open angle glaucomaKivanc Güngör, Mehtap Ozkur, Ingolf Cascorbi, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 12, 2003
Implications of pharmacogenetics for individualizing drug treatment and for study designChristian Meisel, Thomas Gerloff, Julia Kirchheiner, et al.
Genetic Testing|October 6, 2006
Systematic analysis of sequence variability of the endothelin-1 gene: a prerequisite for association studiesKonstanze Diefenbach, Farhad Arjomand-Nahad, Christian Meisel, et al.
European Journal of Clinical Pharmacology|September 17, 2004
Impact of cytochrome P-450 inhibition by cimetidine and induction by carbamazepine on the kinetics of hypericin and pseudohypericin in healthy volunteersAndreas Johne, Elke S Perloff, Steffen Bauer, et al.
Pageof 10